This content is machine translated Continuing education series on type 2 diabetes (2021) Dia-Month Club Module 6: Consequential diseases On November 18, the sixth module of the Dia-Month Club was held on the topic of secondary diseases of type 2 diabetes. Our expert, Dr. Thanh-Truc Ngô Bá (St. Claraspital,… CME-Test
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2021) Dia-Month Club Module 7: Digital Tools On December 9, the seventh and final module of the 2021 Dia-Month Club was held on the topic of digital tools. Our expert, Prof. Roger Lehmann (University Hospital Zurich), explained… CME-Test
View Post 3 min This content is machine translated Advanced pancreatic cancer First-line therapies in the Real Life Check Currently, gemcitabine plus Nab-paclitaxel and FOLFIRINOX are considered standard first-line therapies for advanced pancreatic cancer. So far, there is no direct comparison of these options. An analysis of the German…
View Post 5 min This content is machine translated Type 2 diabetes GLP-1 receptor agonists reduce multiple cardiovascular risk factors In addition to improving glycemic control, GLP-1 receptor agonists have proven additional cardiovascular benefits. Large endpoint studies have demonstrated reductions in myocardial infarction and stroke rates and cardiovascular mortality. Another…
View Post 6 min This content is machine translated Wound Management Silicone-containing wound dressings support pressure ulcer prophylaxis and therapy Prevention and treatment of pressure ulcers are important aspects of everyday medical practice. The use of adequate wound dressings is an essential component and should be criterion-driven. The use of…
View Post 5 min This content is machine translated Type 2 diabetes mellitus SGLT-2 inhibitor has cardioprotective effect in different risk groups Type 2 diabetes mellitus (T2DM) significantly increases the risk of cardiovascular complications [1]. However, SGLT-2 inhibitors may prevent cardiovascular events in addition to lowering blood glucose levels [2, 3]. For…
View Post 4 min This content is machine translated GLP-1 receptor agonists (GLP-1-RA) Type 2 diabetics benefit from dulaglutide in several ways The ADA/EASD guidelines recommend individualized therapy choices for type 2 diabetics. GLP-1 receptor agonists not only improve glycemic control, but also support weight loss, reduce the risk of cardiovascular disease,…
View Post 6 min This content is machine translated Antisynthetase syndromes Watch your fingers The antisynthetase syndromes are a subgroup of the idiopathic inflammatory myopathies and account for approximately 35-40% of cases here. However, if detected in time, the long-term prognosis for affected individuals…
View Post 5 min This content is machine translated Corona pandemic Diabetes patients with COVID-19: current expert assessment. Poorly controlled diabetes is a risk factor for severe COVID-19 progression. Therefore, especially during the corona pandemic, the best possible blood glucose control is crucial. However, it has been shown…
View Post 16 min This content is machine translated Type 2 diabetes The cardiovascular diabetic patient – an interdisciplinary challenge A patient with type 2 diabetes is 2-3 times more likely to have a myocardial infarction or stroke than people without diabetes. Cardiovascular disease accounts for up to 50% of… CME-Test
View Post 13 min This content is machine translated Quantitative sensory testing in neuropathic pain. Comprehensive functional analysis of the somatosensory nervous system Pain is one of the most difficult symptoms to detect. Many other signs of disease, such as skin symptoms or paralysis, are visible, palpable, and thus objectifiable. In the assessment…
